Chandra Bhagat Pharma Approves Allotment of 66 Lakh Preferential Convertible Warrants
Chandra Bhagat Pharma Ltd 路 Others (Uncategorized) 路 22 Oct 2026, 5:59 pm
Chandra Bhagat Pharma Approves Allotment of 66 Lakh Preferential Convertible Warrants Chandra Bhagat Pharma Limited's Board has approved the preferential allotment of 66,00,000 convertible warrants at an issue price of Rs. 44 each (face value Rs. 10) to nine promoter and non-promoter investors. The company received an upfront consideration of Rs. 7.26 cr. Each warrant is convertible into one equity share (1:1 ratio) within 18 months from allotment upon receipt of the remaining consideration. Post-conversion, promoters and promoter group entities will hold the majority, while non-promoters Samir Dave and Chintan Makhecha will each hold 5.66%.
Original exchange filing (PDF)
More announcements from Chandra Bhagat Pharma Ltd
- Outcome of the Board Meeting held on 13th November, 2026. 路 13 Nov 2026
- Outcome of the Board Meeting held on 13th November, 2026 for approval of un-audited result as on 30th September, 2026. 路 13 Nov 2026
- Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Un-audited Result for .... 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Ramkant Dave 路 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chintan Vijay Makhecha 路 27 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hemant Chandravadan Bhagat & PACs 路 26 Oct 2026
- Certificate for Non_Applicability of Corporate Governance Certificate for the quarter ended 30th September, 2026. 路 21 Oct 2026
- The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis. 路 13 Oct 2026
